January 1, 1992Clinical and Experimental Hypertension
The Antiatherogenic Effects of Antihypertensive Drugs: Experimental and Clinical Evidence
Why the study?
Do antihypertensive drugs have an antiatherogenic action independent of their blood pressure-lowering effects?
Population
Experimental models of atherosclerosis and clinical populations
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May support early calcium antagonist use to limit new lesions; leaves open BP-independent effects and advanced-disease utility pending trials.
Key Points
- To evaluate whether distinct antihypertensive drug classes exert antiatherogenic actions independent of their blood pressure-lowering effects in experimental and clinical settings.
- Reviewed experimental studies assessing antihypertensive compounds in animal disease models, including cholesterol-fed cohorts and Watanabe heritable hyperlipemic rabbits.
- Synthesized coronary arteriography data and emerging carotid ultrasound evaluations assessing lesion progression in hypertensive cardiac patients.
- Experimental models demonstrate antiatherogenic efficacy only when drugs are administered concurrently with atherogenic stimuli, showing virtually no effect on established plaques.
- Clinical arteriographic studies confirm that calcium antagonists exert favorable inhibitory effects on new or early lesions while having minimal impact on mature atherosclerotic lesions.
Structured PICO
Do antihypertensive drugs have an antiatherogenic action independent of their blood pressure-lowering effects?
P
Population
Experimental models of atherosclerosis (e.g., cholesterol-fed animals, Watanabe heritable hyperlipemic rabbits) and clinical populations (coronary patients, hypertensive patients)
I
Intervention
Antihypertensive drugs (including calcium antagonists and diuretics)
O
Outcome
Antiatherogenic action (effect on new, early, or well-developed atherosclerotic lesions)surrogate
Antihypertensive drugs, particularly calcium antagonists, may prevent the development of new atherosclerotic lesions but appear ineffective at reversing established plaques.
Cite This Study
Alberto Zanchetti (1992) studied this question.